Robeco Institutional Asset Management B.V. Trims Stock Holdings in Cardinal Health, Inc. (NYSE:CAH)

Robeco Institutional Asset Management B.V. decreased its holdings in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 14.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 832,235 shares of the company's stock after selling 139,825 shares during the quarter. Robeco Institutional Asset Management B.V. owned approximately 0.34% of Cardinal Health worth $114,657,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. Flputnam Investment Management Co. lifted its stake in Cardinal Health by 1.8% during the fourth quarter. Flputnam Investment Management Co. now owns 180,586 shares of the company's stock worth $21,358,000 after purchasing an additional 3,148 shares during the last quarter. Huntington National Bank lifted its stake in Cardinal Health by 1.2% during the fourth quarter. Huntington National Bank now owns 10,920 shares of the company's stock worth $1,292,000 after purchasing an additional 128 shares during the last quarter. Kingswood Wealth Advisors LLC lifted its stake in Cardinal Health by 17.2% during the first quarter. Kingswood Wealth Advisors LLC now owns 3,119 shares of the company's stock worth $429,000 after purchasing an additional 457 shares during the last quarter. Fisher Asset Management LLC purchased a new stake in Cardinal Health during the fourth quarter worth approximately $368,000. Finally, Assenagon Asset Management S.A. lifted its stake in Cardinal Health by 25.8% during the first quarter. Assenagon Asset Management S.A. now owns 13,147 shares of the company's stock worth $1,811,000 after purchasing an additional 2,694 shares during the last quarter. Hedge funds and other institutional investors own 87.17% of the company's stock.

Cardinal Health Price Performance

Shares of NYSE:CAH traded up $1.57 during trading on Friday, reaching $167.18. The company had a trading volume of 2,603,370 shares, compared to its average volume of 2,239,016. The firm has a market capitalization of $39.90 billion, a price-to-earnings ratio of 26.08, a price-to-earnings-growth ratio of 1.85 and a beta of 0.66. The stock's fifty day moving average price is $152.57 and its 200 day moving average price is $135.52. Cardinal Health, Inc. has a fifty-two week low of $93.17 and a fifty-two week high of $168.55.

Cardinal Health (NYSE:CAH - Get Free Report) last released its earnings results on Thursday, May 1st. The company reported $2.35 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.15 by $0.20. The business had revenue of $54.88 billion for the quarter, compared to analyst estimates of $55.33 billion. Cardinal Health had a negative return on equity of 68.84% and a net margin of 0.70%. The company's revenue for the quarter was up .0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.08 earnings per share. On average, equities analysts anticipate that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, July 15th. Shareholders of record on Tuesday, July 1st will be given a dividend of $0.5107 per share. This represents a $2.04 dividend on an annualized basis and a yield of 1.22%. This is an increase from Cardinal Health's previous quarterly dividend of $0.51. The ex-dividend date of this dividend is Tuesday, July 1st. Cardinal Health's payout ratio is presently 31.51%.

Analysts Set New Price Targets

CAH has been the subject of several recent analyst reports. Wells Fargo & Company upgraded Cardinal Health from an "equal weight" rating to an "overweight" rating and boosted their target price for the stock from $136.00 to $179.00 in a research note on Tuesday, June 3rd. Bank of America boosted their target price on Cardinal Health from $165.00 to $170.00 and gave the stock a "buy" rating in a research note on Tuesday, June 10th. Wall Street Zen upgraded Cardinal Health from a "buy" rating to a "strong-buy" rating in a research note on Monday, May 5th. Robert W. Baird lifted their price target on Cardinal Health from $156.00 to $170.00 and gave the stock an "outperform" rating in a research report on Friday, May 2nd. Finally, Morgan Stanley set a $181.00 price target on Cardinal Health and gave the stock an "overweight" rating in a research report on Friday, June 13th. Three equities research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, Cardinal Health currently has an average rating of "Moderate Buy" and a consensus target price of $157.43.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.